CarlosRSanabriaMD

Internal Medicine • West Bend, WI

Hematology/Oncology

Physician

Join to view full profile

Are you Dr. Sanabria?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 38 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
525 S. Silverbrook Dr.
West Bend, WI 53095
Phone+1 262-334-6020

Fax+1 262-334-6067
Is this information wrong?

Summary

Dr. Carlos Sanabria, MD is a board certified internist in West Bend, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Illinois. He is affiliated with Aurora West Allis Medical Center and Aurora St. Luke's Medical Center.

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1991 - 1992
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1984 - 1988
Medical College of WisconsinClass of 1984

Certifications & Licensure

IL State Medical License 1984 - 2026
WI State Medical License 1987 - 2025
American Board of Internal Medicine Internal Medicine

Clinical Trials

A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants Start of enrollment: 2012 Dec 27
Completed
Phase 1
Open Label Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 in Healthy Volunteers Start of enrollment: 2013 Jan 01
Completed
Phase 1
A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris Start of enrollment: 2014 Jun 01
Completed
Phase 1
Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers Start of enrollment: 2014 Aug 01
Completed
Phase 1
Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585 Start of enrollment: 2015 Nov 01
Completed
Phase 1
A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects Start of enrollment: 2016 Apr 25
Completed
Phase 1
CiPA Phase 1 ECG Biomarker Validation Study Start of enrollment: 2017 Mar 14
Completed
Phase 1
A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets Start of enrollment: 2018 Feb 23
Completed
Phase 1
Assessment of the Human Systemic Absorption of Sunscreen Ingredients Start of enrollment: 2018 Jul 18
Completed
Phase 1
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin Start of enrollment: 2019 Jun 18
Completed
Phase 1
Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study Start of enrollment: 2020 Nov 03
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

150 citations
Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.
Murali K. Matta, Robbert Zusterzeel, Nageswara Rao Pilli, Vikram Patel, Donna A. Volpe, Jeffry Florian, Luke Oh, Edward D. Bashaw, Issam Zineh, Carlos Sanabria, Sarah ...> ;JAMA. 2019 Jun 4
58 citations
Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study.
Jose Vicente, Robbert Zusterzeel, Lars Johannesen, Roberto Ochoa‐Jimenez, Jay W. Mason, Carlos Sanabria, Sarah Kemp, Philip T. Sager, Vikram Patel, Murali K. Matta, Ji...> ;Clinical Pharmacology and Therapeutics. 2019 Apr 1
9 citations
NYX-2925, A Novel N-methyl-D-aspartate Receptor Modulator: A First-in-Human, Randomized, Double-blind Study of Safety and Pharmacokinetics in Adults.
David R. Houck, Laurel Sindelar, Carlos Sanabria, Stephanie H. Stanworth, Maggie Krueger, Mary Suh, Torsten M. Madsen> ;Clinical and Translational Science. 2019 Mar 1
10 citations
Evaluation of the Cardiac Safety of Long-Acting Endectocide Moxidectin in a Randomized Concentration-QT Study.
Sally A. Kinrade, Jay W. Mason, Carlos Sanabria, Craig R. Rayner, Julie M. Bullock, Stephanie H. Stanworth, Mark T. Sullivan> ;Clinical and Translational Science. 2018 Nov 1
3 citations
Electrocardiographic Effects of a Supratherapeutic Dose of Oritavancin.
Jay W. Mason, S. Eralp Bellibas, Nuo-Yu Huang, Carlos Sanabria, Borje Darpo> ;Clinical Pharmacology in Drug Development. 2016 Nov 1
100 citations
Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial
Lars Johannesen, Jose Vicente, Jay W. Mason, Cassandra Erato, Carlos Sanabria, Kristin Waite‐Labott, Mira Hong, John Lin, Ping Guo, Abdul Mutlib, Jianyao Wang, William...> ;Clinical Pharmacology and Therapeutics. 2016 Feb 1
175 citations
Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.
Lars Johannesen, Jose Vicente, Jay W. Mason, Carlos Sanabria, K Waite-Labott, M Hong, P Guo, J Lin, J S Sørensen, Loriano Galeotti, Jeffry Florian, Martin Ugander, Nor...> ;Clinical Pharmacology and Therapeutics. 2014 Nov 1
Join now to see all

Hospital Affiliations

Aurora St. Luke's Medical CenterMilwaukee, Wisconsin
Aurora West Allis Medical CenterMilwaukee, Wisconsin